1. Academic Validation
  2. Chronic exposure to polystyrene microplastics triggers osteoporosis by breaking the balance of osteoblast and osteoclast differentiation

Chronic exposure to polystyrene microplastics triggers osteoporosis by breaking the balance of osteoblast and osteoclast differentiation

  • Toxicology. 2025 Jan:510:154017. doi: 10.1016/j.tox.2024.154017.
Chun Pan 1 Runyang Hong 2 Kehan Wang 3 Yujie Shi 2 Zhencheng Fan 2 Tingting Liu 4 Hao Chen 5
Affiliations

Affiliations

  • 1 Department of Orthopedics, Affiliated Hospital of Yangzhou University, Yangzhou, China; Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.
  • 2 Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.
  • 3 Department of Orthopedics, Affiliated Hospital of Yangzhou University, Yangzhou, China.
  • 4 Department of Orthopedics, Affiliated Hospital of Yangzhou University, Yangzhou, China. Electronic address: apptx4869@126.com.
  • 5 Department of Orthopedics, Affiliated Hospital of Yangzhou University, Yangzhou, China. Electronic address: hchen2020@yzu.edu.cn.
Abstract

Plastic pollution is becoming more and more serious, and microplastics (MPs) formed by degradation from plastics significantly threaten the health of Animals and humans. However, it remains unknown how MPs interfere with bone homeostasis by regulating the function of bone marrow mesenchymal stem cells (BMSCs). In order to simulate the toxic impacts of long-term low-dose MPs on the skeletal system, we constructed a 6-month drinking water model of mice exposed to MPs. We found that the bone microstructure in the femur of mice exposed to MPs was destroyed, the quantity of bone trabeculae decreased sharply and the bone mass decreased significantly, accompanied by the decrease of bone formation and the activation of osteoclasts. In addition, RNA Sequencing showed NF-κB pathway was activated in MPs-treated BMSCs, manifested as significantly up-regulated inflammatory factors, accelerated the senescence of BMSCs, and inhibited their osteogenic differentiation and extracellular mineralization. Senescent BMSCs induced by MPs led to the overproduction of RANKL, which contributed to the production of more osteoclasts. Importantly, the administration of NF-κB inhibitors in vivo markedly diminished MPs-induced BMSCs senescence and impaired osteogenic differentiation. Meanwhile, the secretion of RANKL caused by MPs was reversed, and osteoclast formation was significantly reduced. In summary, our data innovatively reveal the core mechanism of MPs in bone balance. By promoting the NF-κB signaling pathway, it significantly accelerates the aging of BMSCs, causes a decrease in bone formation, and promotes osteoclast formation through RANKL.

Keywords

Bone marrow mesenchymal stem cells; Microplastics; NF-κB; Osteoclast; Polystyrene.

Figures
Products
Inhibitors & Agonists
Other Products